Revenio Group Oyj (HEL:REG1V)

Finland flag Finland · Delayed Price · Currency is EUR
22.15
+0.35 (1.61%)
At close: Dec 5, 2025
-19.80%
Market Cap 589.26M
Revenue (ttm) 109.32M
Net Income (ttm) 18.50M
Shares Out 26.60M
EPS (ttm) 0.69
PE Ratio 31.98
Forward PE 24.36
Dividend 0.40 (1.83%)
Ex-Dividend Date Apr 11, 2025
Volume 23,458
Average Volume 25,135
Open 21.75
Previous Close 21.80
Day's Range 21.75 - 22.20
52-Week Range 21.35 - 31.88
Beta 1.36
RSI 44.14
Earnings Date Feb 11, 2026

About Revenio Group Oyj

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used for mea... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2001
Employees 241
Stock Exchange Nasdaq Helsinki
Ticker Symbol REG1V
Full Company Profile

Financial Performance

In 2024, Revenio Group Oyj's revenue was 103.82 million, an increase of 7.27% compared to the previous year's 96.79 million. Earnings were 18.50 million, a decrease of -3.20%.

Financial Statements

News

Revenio Group Oyj (REVXF) Q3 2025 Earnings Call Highlights: Strong European Growth and ...

Revenio Group Oyj (REVXF) Q3 2025 Earnings Call Highlights: Strong European Growth and Strategic US Launches Amid Currency Challenges

5 weeks ago - GuruFocus

Q3 2025 Revenio Group Oyj Earnings Call Transcript

Q3 2025 Revenio Group Oyj Earnings Call Transcript

5 weeks ago - GuruFocus